Before The Bell
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Baxter International Inc. (BAX)

4/17/2012 7:40 AM ET

Baxter International Inc. (BAX: Quote) and Halozyme Therapeutics (HALO: Quote) announced Monday morning that the FDA has requested additional information to complete its review of the HyQ Biologics License Application.

Baxter International gapped open sharply lower Monday and fell during the first half hour of trade. The stock was range-bound for the remainder of the session and closed down by 3.93 at $54.10 on the highest volume of the year. Baxter sank to over a 2 1/2 month low and fell below its 200-day moving average.

Click here to receive FREE breaking news email alerts for Baxter International Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

comments powered by Disqus